Immunoassays for the diagnosis of HIV: Meeting future needs by enhancing the quality of testing

Future Microbiology

Volumn 4, Issue 8, 2009, Pages 963-982

  Chappel, Roderick J ^a   Wilson, Kim M ^a   Dax, Elizabeth M ^a  

^a National Serology Reference Laboratory   (Australia)

Author keywords

Assay performance; HIV; HIV detection and diagnosis; Immunoassay; Incidence assay; Quality; Quality management; Rapid testing

Indexed keywords

ANTIGEN P24; RNA DIRECTED DNA POLYMERASE;

ANTIGEN ANTIBODY COMPLEX; DIAGNOSTIC ACCURACY; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; INCIDENCE; NEWBORN INFECTION; PERFORMANCE MEASUREMENT SYSTEM; PREVALENCE; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; VIRUS LOAD; WESTERN BLOTTING;

ADULT; ALGORITHMS; HIV ANTIBODIES; HIV ANTIGENS; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOASSAY; INCIDENCE; INFANT, NEWBORN; QUALITY CONTROL; REAGENT KITS, DIAGNOSTIC; TIME FACTORS;

EID: 70449372264     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/fmb.09.77     Document Type: Review

References (96)

1. Clark JL, Coates TJ, Lescano AG et al.: Different positive predictive values of commercially available human immunodeficiency virus enzyme-linked immunosorbent assays. Clin. Vaccine Immunol. 13, 302-303 (2006).
2. Metadilogkul O, Jirathitikal V, Bourinbaiar AS: Serodeconversion of HIV antibody-positive AIDS patients following treatment with V-I immunonitor. J. Biomed. Biotechnol. e934579 (2009).
3. Busch MP, Satten GA: Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure. Am. J. Med. 102, 117-124 (1997).
4. Iqbal HS, Balakrishnan P, Cecelia AJ et al.: Use of an HIV-1 reverse-transcriptase enzyme-activity assay to measure HIV-1 viral load as a potential alternative to nucleic acid-based assay for monitoring antiretroviral therapy in resource-limited settings. J Med. Microbiol. 56, 1611-1614 (2007). (Pubitemid 350276510)
5. Rogan PD: Current serological methods of testing and automation. In: Transfusion Microbiology. Barbara JAJ, Regan FAM, Contreras M (Eds). Cambridge University Press, Cambridge, UK (2008).
6. Fearon, M: The laboratory diagnosis of HIV infections. Can. J. Infect. Dis. Med. Microbiol. 16, 26-30 (2005).
7. Constantine NT, Saville RD, Dax EM: Retroviral Testing and Quality Assurance: Essentials for Laboratory Diagnosis. Malloy Printers, MI, USA 81-701 (2005). • Full review of HIV testing, its quality and its issues.
8. Everett DB, Weiss HA, Changalucha J et al.: Low specificity of the Murex fourth-generation HIV enzyme immunoassay in Tanzanian adolescents. Trop. Med. Int. Health 12, 1323-1326 (2007).
9. Dax EM, Walker S: Advances in quality assurance of laboratory testing for transfusion safety. In: Advances in Transfusion Safety. Dax EM, Farrugia A, Vyas GN (Eds). Karger, Basel, Switzerland (2007).
10. de Castro AC, Borges LGD, de Souza RD, Grudzinski M, D'Azevedo PA: Evaluation of the human immunodeficincy virus type 1 and 2 antibodies detection in dried whole blood spots (DBS) samples. Rev. Inst. Med. Trop. Sao Paulo 50, 151-156 (2008).
11. Dodd R, Kurt Roth W, Ashford P, Dax EM, Vyas G: Transfusion medicine and safety. Biologicals 37, 62-70 (2009).
12. Healey DS, Maskill WJ, Howard TS et al.: HIV-1 western blot: development and asessment of testing to resolve indeterminate reactivity AIDS 6, 629-633 (1992). • One of the few published method for the management of indeterminate western blot results.
13. Kannangai R, Kandathil AJ, Daniel HD, Prasannakumar S, Lionnel J, Abraham P: An unusual seroconversion profile in a pregnant woman infected with the human immunodeficiency virus-1: need for using later generations HIV screening assays. Indian J. Med. Microbiol. 26, 390-392 (2008).
14. Sickinger E, Stieler M, Kaufman B et al.: Multicenter evaluation of a new, automated enzyme-linked immunoassay for detection of human immunodeficiency virus-specific antibodies and antigen J. Clin. Microbiol. 42, 21-29 (2004).
15. Plate DK: Rapid HIV Test Evaluation Working Group: Evaluation and implementation of rapid HIV tests: the experience in 11 African countries. AIDS Res. Hum. Retroviruses 23, 1491-1498 (2007).
16. Ly TD, Laperche S, Brennan C et al.: Evaluation of the sensitivity and specificity of six HIV combined p24 antigen and antibody assays. J. Virol. Methods 122, 185-194 (2004). (Pubitemid 39470190)
17. Weber B, Orazi B, Raineri A et al.: Multicenter evaluation of a new 4th generation HIV screening assay Elecsys HIV combi. Clin. Lab. 52, 463-473 (2006).
18. Ly TD, Martin L, Daghfal D et al.: Seven human immunodeficiency virus (HIV) antigen-antibody combination assays: evaluation of HIV seroconversion sensitivity and subtype detection. J. Clin. Microbiol. 39, 3122-3128 (2002).
19. Cunningham P, Downie J, O'Loughlin P, Evans S, Black J: Incremental detection of HIV infections by the HIV antigen/antibody combination assays: an Australian experience. J. Med. Virol. 79, S16-S22 (2007).
20. Skidmore S, Devendra S, Weaver J, Short J, Osman H, Smit E: A case study of delayed HIV-1 seroconversion highlights the need for combo assays. Int. J. STD AIDS 20, 205-206 (2009).
21. Mundee Y, Kamtorn N, Chaiyaphruk S, Nantachit N, Ness PM, Nelson KE: Infectious disease markers in blood donors in northern Thailand. Transfusion 35, 264-267 (1995).
22. Dax EM, Arnott A: Advances in laboratory testing for HIV. Pathology 36, 551-560 (2004).
23. Perry KR, Ramskill S, Elgin RP, Barbara JAJ, Parry JV: Improvement in the performance of HIV screening kits. Transfus. Med. 18, 228-240 (2008). • Most up-to-date synopsis of the evolution of HIV immunoassay development over time.
24. Learmonth KM, McPhee DA, Dax EM: Point of care testing using simple/rapid tests. Microbiol. Aust. 82-84 (2006).
25. Owen SM, Yang C, Spira T et al.: Alternative algorithms for human immunodeficiency virus infection diagnosis using tests that are licensed in the United States. J. Clin. Microbiol. 46, 1588-1595 (2008).
26. Walensky RP, Freedberg KA, Weinstein MC, Paltiel AD: Cost-effectiveness of HIV testing and treatment in the United States. Clin. Infect. Dis. 45(Suppl. 4), S248-S254 (2007).
27. Huang, L-J, Liu C-Y, Chu S-C et al.: Predictive value of two commercial human immunodeficiency virus serological tests in cases with indeterminate western blot results. J. Microbiol. Immunol. Infect. 39, 219-224 (2006).
28. Willman JH, Hill HR, Martins TB, Jaskowski TD, Ashwood ER, Litwin CM: Multiplex analysis of heterophil antibodies in patients with indeterminate HIV immunoassay results Am. J. Clin. Pathol. 115, 764-769 (2001).
29. Mahé C, Kaleebu P, Ojwiya A, Whitworth JA: Human immunodeficiency virus type 1 western blot: revised diagnostic criteria with fewer indeterminate results for epidemiological studies in Africa. Int. J. Epidemiol. 31, 985-990 (2002).
30. Tebourski F, Slim A, Elgaaied A: The significance of combining World Health Organization and Center for Disease Control criteria to resolve indeterminate human immunodeficiency virus type-1 western blot results. Diagn. Microbiol. Infect. Dis. 48, 59-61 (2004).
31. Chan PA, Wakeman SE, Flanigan T, Cu-Uvin S, Kojic E, Kantor R: HIV-diagnosis and quantification in high-risk patients. AIDS Res. Ther. 5, 1-5 (2008).
32. Walther L, Putkonen P, Dias F, Biberfeld G, Thorstensson R: Evaluation of HIV-1/HIV-2 immunoblots for detection of HIV-2 antibodies. Clin. Diagn. Virol. 4, 67-79 (1995).
33. Guan M: Frequency, causes, and new challenges of indeterminate results in western blot confirmatory testing for antibodies to human immunodeficiency virus. Clin. Vaccine Immunol. 14, 649-659 (2007).
34. Update: HIV counseling and testing using rapid tests - United States, 1995. J. Am. Med. Assoc. 279, 1158-1159 (1998).
35. Chanbancherd P, Limpairoin N, de Souza MS et al.: Evaluation of a new fourth-generation microwell enzyme-linked immunosorbent assay for detection of HIV-1 subtype B and E antibodies. Southeast Asian J. Trop. Med. Pub. Health 32, 177-179 (2001).
36. Weber B, Thorstensson R, Tanprasert S, Schmitt U, Melchior W: Reduction of the diagnostic window in three cases of human immunodeficiency-1 subtype E primary infection with fourth-generation HIV screening assays Vox Sang. 85, 73-79 (2003).
37. Swaminathan S, Hanna LE, Sundaramurthi JC et al.: Prevalence and pattern of cross-reacting antibodies to HIV in patients with tuberculosis. AIDS Res. Hum. Retroviruses 24, 941-946 (2008).
38. Hussain T, Sinha S, Katoch K et al.: Serum samples with patients with mycobacterial infections cross-react with HIV structural proteins Gp41, p55 and p18. Lepr. Rev. 78, 137-147 (2007).
39. Weber B, Moshtaghi-Boronjeni M, Brunner M, Preiser W, Breiner M, Doerr HW: Evaluation of the reliability of 6 current anti-HIV-1/HIV-2 enzyme immunoassays. J. Virol. Methods 55, 97-104 (1995).
40. Barbara JAJ, Kitchen AD: Quality in the screening of donations for transfusion-transmissible infections. In: Transfusion Microbiology. Barbara JAJ, Regan FAM, Contreras M (Eds). Cambridge University Press, Cambridge, UK (2008). ■■ Summarizes the importance of quality assurance and quality management in the use of HIV immunoassays.
41. Gust A, Walker S, Chappel RJ, Dax EM: Anti-HIV quality assurance programs in Australia and the southeast Asian and western Pacific regions. Accred. Qual. Assur. 6, 168-172 (2001).
42. Cole MJ, Perry KR, Parry JV: Comparative evaluation of 15 serological assays for the detection of syphilis infection. Eur. J. Clin. Microbiol. Infect. Dis. 26, 705-713 (2007).
43. Crofts N, Maskill W, Gust ID: Evaluation of enzyme-linked immunosorbent assays: a method of data analysis. J. Virol. Methods 22, 51-59 (1988). (Pubitemid 19007884)
44. Peddecord KM, Benenson AS, Hofherr LK et al.: Analytic results of HIV-1 testing using blind proficiency testing. Clin. Lab. Sci. 5, 165-171 (1992).
45. LaMotte LC, Guerrant GO, Lewis DS, Hall CT: Comparison of laboratory performance with blind and mail-distributed proficiency testing samples. Public Health Rep. 92, 554-560 (1977).
46. Parekh BS, McDougal JS: Application of laboratory methods for estimation of HIV-1 incidence. Indian J. Med. Res. 121, 510-518 (2005).
47. Barnighausen T, Wallrauch C, Welte A et al.: HIV incidence in rural South Africa: comparison of estimates from longitudinal surveilance and cross-sectional cBED assay testing. PLoS ONE3, e3640 (2008).
48. Murphy G, Parry JV: Assays for the detection of recent infections with human immunodeficiency virus type 1. Eurosurveillance 13, 4-10 (2008). • Review of available incidence assays and their ability to generate accurate estimates of incidence.
49. Janssen RS, Satten GA, Stramer SL et al.: New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. J. Am. Med. Assoc. 280, 42-48 (1998).
50. Rutherford GW, Schwarcz SK, McFarland W: Surveillance for incident HIV infection: new technology and new opportunities. J. Acquir. Immune Defic. Syndr. 25(Suppl. 2), S115-S119 (2000).
51. Parekh BS, Hu DJ, Vanichseni S et al.: Evaluation of a sensitive/less sensitive testing algorithm using the 3A11-LS assay for detecting recent HIV serovonversion among individuals with HIV-1 subtype B or E infection in Thailand. AIDS Res. Hum. Retroviruses 17, 453-458 (2001).
52. Kothe D, Byers RH, Caudill SP et al.: Performance characteristics of a new less sensitive HIV-1 enzyme immunoassay for use in estimating HIV seroincidence. J. Acquir. Immune Defic. Syndr. 33, 625-634 (2003).
53. Young CL, Hu DJ, Byers RH et al.: Evaluation of a sensitive/less sensitve testing algorithm using the bioMerieux Vironostika-LS assay for detecting recent HIV-1 subtype B' or E infection in Thailand. AIDS Res. Hum. Retroviruses 19, 481-486 (2003).
54. Wilson KM, Johnson EI, Croom HA et al.: Incidence immunoassay for distinguishing recent from established HIV-1 infection in therapy-naive populations. AIDS 18, 2253-2259 (2004).
55. Parekh BS, Kennedy MS, Dobbs T et al.: Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. AIDS Res. Hum. Retroviruses 18, 295-307 (2002).
56. Guy RJ, Breschkin AM, Keenan CM, Catton MG, Enriquez AM, Hellard ME: Improving HIV surveillance in Victoria: the role of the 'detuned' enzyme immunoassay. J. Acquir. Immune Defic. Syndr. 38, 495-499 (2005).
57. Hargrove JW, Humphrey JH, Mutasa K et al.: Improved HIV-1 incidence estimates using the BED capture enzyme enyzyme immunoassay. AIDS 22, 511-518 (2008). (Pubitemid 351317293)
58. Hayashida T, Gatanaga H, Tanuma J, Oka S: Effects of low HIV type 1 load and antiretroviral treatment on IgG-capture BED-enzyme immunoassay. AIDS Res. Hum. Retroviruses 24, 495-498 (2008).
59. Li H, Ketema F, Sill AM, Kreisel KM, Cleghorn FR, Constantine NT: A simple and inexpensive particle agglutination test to distinguish recent from established HIV-1 infection. Int. J. Infect. Dis. 11, 459-465 (2007).
60. Kshatriya R, Cachafeiro AA, Kerr RJ, Nelson JA, Fiscus SA: Comparison of two rapid human immunodeficiency virus (HIV) assays, Determine HIV-1/2 and OraQuick Advance Rapid HIV-1/2, for detection of recent HIV seroconversion. J. Clin. Microbiol. 46, 3482-3483 (2008).
61. McDougal JS, Parekh BS, Peterson ML et al.: Comparison of HIV type 1 incidence observed during longitudinal follow-up with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassay. AIDS Res. Hum. Retroviruses 22, 945-952 (2006).
62. Hladik W, Olara D, Ertr W, Mermin J, Downing R: The effect of antiretroviral treatment on the specificity of the serological BED HIV-1 incidence assay. Presented at: HIV Implementers Meeting. Kigali, Rwanda, 16-19 June 2007.
63. Suliqoi B, Massi M, Galli C et al.: Identifying recent HIV infections using the avidity index and an automated enzyme immunoassay. J. Acquir. Immune Defic. Syndr. 32, 424-428 (2003).
64. Chawla A, Murphy G, Donnelly C et al.: Human immunodeficiency virus (HIV) antibody avidity testing to identify recent infection in newly diagnosed HIV type 1 seropositive persons infected with diverse HIV-1 subtypes. J. Clin. Microbiol. 45, 415-420 (2007).
65. Wilson KM, C Di Camillo, Doughty L, Dax EM: Humoral immune response to primary rubella virus infection. Clin. Vaccine Immunol. 13, 380-386 (2006).
66. Binley JM, Arshad H, Fours TR, Moore JP: An investigation of the high-avidity antibody response to glycoprotein 120 of human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses 13, 1007 (1997).
67. Barin F, Meyer L, Lancar R et al.: Development and validation of an immunoassay for identification of recent human immunodeficiency virus type 1 infection and its use on dried serum spots. J. Clin. Microbiol. 43, 4441-4447 (2005).
68. Schupbach J, Gebhardt MD, Tomasik Z et al.: Assessment of recent HIV-1 infection by a line immunoassay for HIV-1/2 confirmation. PLoS Med. 4, e343 (2007).
69. Anon: Workshop on the serological testing algorithm for recent HIV seroconversion (STARHS) and HIV incidence estimates, Stockholm, 11-12 March 2008. Eurosurveillance 13, 1-2 (2008).
70. Bernstein HB, Kinter AL, Jackson R, Fauci AS: Neonatal natural killer cells produce chemokines and suppress HIV replication in vitro. AIDS Res. Hum. Retroviruses 20, 1189-1195 (2004).
71. Hahn T, Ramakrishnan R, Ahmad N: Evaluation of genetic diversity of human immunodeficiency virus type 1 NEF gene associated with vertical transmission. J. Biomed. Sci. 10, 436-450 (2003).
72. Ou CY, Yang H, Balinandi S et al.: Identification of HIV-1 infected infants and young children using real-time RT PCR and dried blood spots from Uganda and Cameroon. J. Virol. Methods 144, 109-114 (2007).
73. Henrard D, Fauvel M, Samson J et al.: Ontogeny of the humoral immune response to human immunodeficiency virus type 1 in infants. J. Infect. Dis. 168, 288-291 (1993).
74. Luo W, Yang H, Rathbun K, Pau CP, Ou CY: Detection of human immunodeficiency virus type 1 DNA in dried blood spots by a duplex real-time PCR assay. J. Clin. Microbiol. 43, 1851-1857 (2005).
75. Young NL, Shaffer N, Chaowanachan T et al.: Early diagnosis of HIV-1 infected infants in Thailand using RNA and DNA PCR assays sensitive to non-B subtypes. J. Acquir. Immune Defic. Syndr. 24, 401-407 (2000).
76. Cunningham CK, Charbonneau TT, Song K et al.: Comparison of human immunodeficiency virus 1 DNA polymerase chain reaction and qualitative and quantitative RNA polymerase chain reaction in human immunodeficiency virus 1-exposed infants. Pediatr. Infect. Dis. J. 18, 30-35 (1999).
77. Guay LA, Hom DL, Kabengera SR et al.: HIV-1 ICD p24 antigen detection in Ugandan infants: use in early diagnosis of infection and as a marker of disease progression. J. Med. Virol. 62, 426-434 (2000).
78. Patton JC, Coovadia AH, Meyers TM, Sherman GG: Evaluation of the ultrasensitive human immunodeficiency virus type 1 (HIV-1) p24 antigen assay performed on dried blood spots for diagnosis of HIV-1 infection in infants. Clin. Vaccine Immunol. 15, 388-391 (2008).
79. Basualdo Mdel C, Moran K, Alcantara P, Gonzales E, Puentes E, Soler C: IgA antibody detection and PCR as first options in the diagnosis of perinatal HIV-1 infection. Salud Publica Mex. 46, 49-55 (2004). (Pubitemid 38428748)
80. Franco-Paredes C, Tellez I, del Rio C: Rapid HIV testing: a review of the literature and implications for the clinician. Curr. HIV/AIDS Rep. 3, 169-175 (2006). (Pubitemid 44657375)
81. Everett DB, Baisley K, Changalucha J et al.: Suitability of simple human immunodeficiency virus rapid tests in clinical trials in community-based clinic settings. J. Clin. Microbiol. 47, 1058-1062 (2009).
82. Walensky RP, Arbelaez C, Reichmann WM et al.: Revising expectations from rapid HIV tests in the emergency department. Ann. Intern. Med. 149, 153-160 (2008).
83. Dietz CA, Ablah E, Reznik D, Robbins DK: Patients' attitudes about rapid oral HIV screening in an urban, free dental clinic. AIDS Patient Care STDS 22, 205-212 (2008).
84. Delaney KP, Branson BM, Uniyal A et al.: Performance of an oral fluid rapid HIV-1/2 test: experience from four CDC studies. AIDS 20, 1655-1660 (2006). (Pubitemid 44162408)
85. Wesolowski LG, MacKellar DA, Facente SN et al.: Post-marketing surveillance of OraQuick whole blood and oral fluid rapid. HIV testing. AIDS 20, 1661-1666 (2006).
86. Connell JA, ParryJV, Mortimer PP, Duncan J: Novel assay for the detection of immunoglobulin G antihuman immunodeficiency virus in untreated saliva and urine. J. Med. Virol. 41, 159-164 (1993).
87. Parry JV, Perry KR, Mortimer PP: Sensitive assays for viral antibodies in saliva: an alternative to tests on serum. Lancet 2 (8550), 72-75 (1987).
88. Klarkowski DB, Wazome JM, Lokuge KM, Shanks L, Mills CF, O'Brien DP: The evaluation of a rapid in situ HIV confirmation test in a programme with a high failure rate of the WHO HIV two-test diagnostic algorithm. PLoS ONE 4, e4351 (2009). ■■ Illustrating the fact that HIV-testing strategies can fail to be specific, despite the individual component tests performing at a high level.
89. Odaibo GN, Donbraye E, Adewumi MO, Bakarey AS, Ibeh MA, Olaleye DO: Reliability of testing and potential impact on HIV prevention in Nigeria. Afr. J. Med. Med. Sci. 35(Suppl.), 131-135 (2006).
90. Pai NP, Tulsky JP, Cohan D, Colford JM Jr, Reingold AL: Rapid point-of-care HIV testing in pregnant women: a sytematic review and meta-analysis. Trop. Med. Int. Health 12, 162-173 (2007).
91. Zelin J, Garrett N, Saunders J et al.: An evaluation of the performance of OraQuick® ADVANCE rapid HIV-1/2 test in a high-risk population attending genitourinary medicine clinics in East London, UK. Int. J. STD AIDS 19, 665-667 (2008).
92. Learmonth KM, McPhee DA, Jardine DK, Walker SK, Aye T-T, Dax EM: Assessing proficiency of interpretation of rapid human immunodeficiency virus assays in nonlaboratory settings: ensuring quality of testing. J. Clin. Microbiol. 46, 1692-1697 (2008).
93. False-Positive Oral Fluid Rapid HIV Tests - New York City, 2005-2008. www.cdc.gov/mmwr/preview/mmwrhtml/mm57e618a1.htm
94. WHO Operational Characteristics publications. http://whqlibdoc.who.int/ hq/1999/WHO-BTS-99.1.pdf; http://whqlibdoc.who.int/publications/2004/9241592370. pdf ■ Ready guide to comparative performances of HIV immunoassays.
95. UNAIDS 2007 AIDS Epidemic Update. www.unaids.org/en/KnowledgeCentre/ HIVData/EpiUpdate/EpiUpdArchive/2007
96. Guidelines for assuring the accuracy and reliability of HIV rapid testing: applying a quality system approach. http://whqlibdoc.who.int/ publications/2005/9241593563-eng.pdf